Bristol-Myers Squibb
BMY
#187
Rank
NZ$215.19 B
Marketcap
NZ$105.35
Share price
-0.77%
Change (1 day)
37.15%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$7.91

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$8.09. In 2025 the company made an earnings per share (EPS) of NZ$6.17 an increase over its 2024 EPS that were of NZ-$7.88.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.9128.28%
2025NZ$6.17-178.28%
2024NZ-$7.88-213.92%
2023NZ$6.9130.2%
2022NZ$5.31-6.04%
2021NZ$5.65-179.29%
2020NZ-$7.13-281.37%
2019NZ$3.93-27.21%
2018NZ$5.40
2016NZ$4.76175.26%
2015NZ$1.73-19.83%
2014NZ$2.16-22.44%
2013NZ$2.7834.48%
2012NZ$2.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.56 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.36-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.25 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.90 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.39-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$10.12 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.26-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.90 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK